GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (STU:AJW) » Definitions » Institutional Ownership

AnGes (STU:AJW) Institutional Ownership : 1.16% (As of Dec. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is AnGes Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AnGes's institutional ownership is 1.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AnGes's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AnGes's Float Percentage Of Total Shares Outstanding is 0.00%.


AnGes Institutional Ownership Historical Data

The historical data trend for AnGes's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnGes Institutional Ownership Chart

AnGes Historical Data

The historical data trend for AnGes can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 0.70 0.69 0.69 0.64 0.59 1.14 1.13 1.09 1.13 1.16

AnGes Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


AnGes Business Description

Industry
Traded in Other Exchanges
Address
7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

AnGes Headlines

No Headlines